FOOD AND DRUG ADMINISTRATION

CENTER FOR BIOLOGICS EVALUATION AND RESEARCH

VACCINES AND RELATED BIOLOGICAL PRODUCTS ADVISORY COMMITTEE

MEETING ON INFLUENZA VIRUS VACCINE FORMULATION FOR 2004-2005

MEETING BY TELECONFERENCE

DRAFT AGENDA

Wednesday, March 17, 2004

Food and Drug Administration

Rockville Pike

* Building 29B, Conference Room C

Rockville, MD

1:00 PM EST

1:00 PM Call to Order Acting Committee Chair

1:05 PM Announcements Christine Walsh, FDA

1:10 PM Open Session

Influenza B Component for Strain Selection for the Influenza Virus Vaccine for 2004 - 2005

Introduction and Review Dr. Levandowski, FDA

Update on Influenza B Virus Activity Dr. Nancy Cox, CDC

1:40 PM Committee Discussion

2:00 PM Open Public Hearing

3:00 PM Committee Discussion: Recommendations for Influenza B Virus

Component for 2004-2005 Influenza Virus Vaccine

3:45 PM Adjournment

* A speakerphone will be provided at the above location for public participation